The Journal of Japan Atherosclerosis Society
Online ISSN : 2185-8284
Print ISSN : 0386-2682
ISSN-L : 0386-2682
The Mode of Lipid-lowering Drugs
-Vitamin Derivatives-
Kohji SHIRAIYasushi SAITO
Author information
JOURNAL OPEN ACCESS

1985 Volume 13 Issue 2 Pages 285-290

Details
Abstract
Vitamins are co-enzymes involved in carbohydrate or lipid metabolisms. Some vitamins or their derivatives have lipid-lowering effect; VB5 (nicotinicacid), VB2 (riboflavin) VB3 (pantethine). Double Blind tests for there drugs show 10-15% reduction of total cholesterol and 5-30% reduction of triglyceride. Another expected advantages of these vitamines are anti-atherosclerotic action not only through their own properies, but also through another actions. Nicotinic acid derivatives enhanced lipoprotein lipase activity, and acid cholesterol esterase activity in the arterial wall. Pantethine prevented the cell necrosis, probably by protecting the mitochondrial swelling induced by fatty acids. α-Tocopherol, anti-oxidant stabilized the membrane bound enzyme activity, e. g. acid cholesterol esterase by fascilitating the binding of the enzyme to lysosomal membrane. These actions in addition to their own properties may contribute to the anti-atherosclerotic action.
Content from these authors
© Japan Atherosclerosis Society

This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-nc-sa/4.0/
Previous article Next article
feedback
Top